Amount Raised
$120 Million
Round Type
Post-IPO Equity
San DiegoBiotechnologyTherapeuticsPharmaceuticalBiopharmaDescription
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, announced today it has agreed to sell approximately 16.6 million shares of its common stock to a select group of institutional and accredited investors in a private placement, at a price per share of $7.21. Gross proceeds are expected to be approximately $120 million, before deducting offering expenses. The financing is expected to close on July 15, 2022, subject to customary closing conditions.
Quick answer
Gossamer Bio raised $120 Million in a Post-IPO Equity round, dated July 13, 2022. Gossamer Bio is based in San Diego, California, United States.
- How much did Gossamer Bio raise?
- Gossamer Bio raised $120 Million in a Post-IPO Equity round on July 13, 2022.
- What does Gossamer Bio do?
- Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
- Where is Gossamer Bio based and how big is it?
- Gossamer Bio is based in San Diego, California, United States. Fundz records about 170 employees.
- Who are the decision-makers at Gossamer Bio?
- Fundz holds 1 contact at Gossamer Bio, including the Executive Officer, Director. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Gossamer Bio that raised within 45 days of this round, from Fundz verified event records.
- LumaBridge raised an undisclosed amount (Private Equity) on August 23, 2022.
- Structure Therapeutics raised an undisclosed amount (Funding Round) on August 1, 2022.
- MIRA Pharmaceuticals raised $625K (Seed) on July 22, 2022.
- Entero Therapeutics raised $300K (Seed) on July 15, 2022.
- Avelos Therapeutics raised an undisclosed amount (Series A) on August 22, 2022.
- Kymera raised $150M (Post-IPO Equity) on August 19, 2022.
Who to call at Gossamer Bio, and when
A new round usually means Gossamer Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Gossamer Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gossamer Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gossamer Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gossamer Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Gossamer Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.